A Forbes article reporting on the Swedish American Life Science Summit (SALSS) in Stockholm, which gathered global scientists and investors to discuss innovations in healthcare such as robotics, nanotechnology, and cancer research. The article highlights the shift in the pharmaceutical industry towards collaboration with startups and "impact investing" to address chronic diseases in an aging population, featuring insights from various industry leaders.
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein entity